(Q46938051)

English

Liquid chromatography/tandem mass spectrometry characterization of oxidized amyloid beta peptides as potential biomarkers of Alzheimer's disease.

scientific article published in January 2006

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16470704%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

Liquid chromatography/tandem mass spectrometry characterization of oxidized amyloid beta peptides as potential biomarkers of Alzheimer's disease (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16470704%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

Alzheimer's disease

0 references

1 reference

based on heuristic

inferred from title

liquid chromatography-tandem mass spectrometry

1 reference

based on heuristic

inferred from title

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16470704%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

author name string

Koichi Inoue

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16470704%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

Carlos Garner

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16470704%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

Bradley L Ackermann

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16470704%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

Ian A Blair

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16470704%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

publication date

1 January 2006

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16470704%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

Rapid Communications in Mass Spectrometry

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16470704%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

20

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16470704%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16470704%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

911-918

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16470704%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

Amyloid, the presenilins and Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1002%2FRCM.2395

21 January 2018

The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics

1 reference

https://api.crossref.org/works/10.1002%2FRCM.2395

21 January 2018

Alzheimer's disease: Initial report of the purification and characterization of a novel cerebrovascular amyloid protein

1 reference

https://api.crossref.org/works/10.1002%2FRCM.2395

21 January 2018

Amyloid plaque core protein in Alzheimer disease and Down syndrome

1 reference

https://api.crossref.org/works/10.1002%2FRCM.2395

21 January 2018

The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor

1 reference

https://api.crossref.org/works/10.1002%2FRCM.2395

21 January 2018

Possible mechanisms of APP-mediated oxidative stress in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1002%2FRCM.2395

21 January 2018

The metallobiology of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1002%2FRCM.2395

21 January 2018

Contribution of redox-active iron and copper to oxidative damage in Alzheimer disease

1 reference

https://api.crossref.org/works/10.1002%2FRCM.2395

21 January 2018

Redox-active metals, oxidative stress, and Alzheimer's disease pathology

1 reference

https://api.crossref.org/works/10.1002%2FRCM.2395

21 January 2018

The role of beta amyloid in Alzheimer's disease: still a cause of everything or the only one who got caught?

1 reference

https://api.crossref.org/works/10.1002%2FRCM.2395

21 January 2018

Therapeutic strategies for Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1002%2FRCM.2395

21 January 2018

CSF biomarkers for mild cognitive impairment

1 reference

https://api.crossref.org/works/10.1002%2FRCM.2395

21 January 2018

CSF biomarkers for mild cognitive impairment and early Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1002%2FRCM.2395

21 January 2018

Decreased levels of soluble amyloid beta-protein precursor in cerebrospinal fluid of live Alzheimer disease patients

1 reference

https://api.crossref.org/works/10.1002%2FRCM.2395

21 January 2018

Advances in the detection of Alzheimer's disease-use of cerebrospinal fluid biomarkers

1 reference

https://api.crossref.org/works/10.1002%2FRCM.2395

21 January 2018

Development of a specific ELISA for the quantitative study of amino-terminally truncated beta-amyloid peptides

1 reference

https://api.crossref.org/works/10.1002%2FRCM.2395

21 January 2018

Amyloid beta 38, 40, and 42 species in cerebrospinal fluid: more of the same?

1 reference

https://api.crossref.org/works/10.1002%2FRCM.2395

21 January 2018

Concentrations of amyloid beta protein in cerebrospinal fluid of patients with Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1002%2FRCM.2395

21 January 2018

Low cerebrospinal-fluid concentrations of soluble amyloid beta-protein precursor in hereditary Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1002%2FRCM.2395

21 January 2018

Age-dependent change in the levels of Abeta40 and Abeta42 in cerebrospinal fluid from control subjects, and a decrease in the ratio of Abeta42 to Abeta40 level in cerebrospinal fluid from Alzheimer's disease patients.

1 reference

https://api.crossref.org/works/10.1002%2FRCM.2395

21 January 2018

Cerebrospinal fluid beta-amyloid1-42 and tau in control subjects at risk for Alzheimer's disease: the effect of APOE epsilon4 allele

1 reference

https://api.crossref.org/works/10.1002%2FRCM.2395

21 January 2018

Amyloid beta(1-42) and phosphorylated tau in CSF as markers for early-onset Alzheimer disease

1 reference

https://api.crossref.org/works/10.1002%2FRCM.2395

21 January 2018

Cerebrospinal fluid amyloid beta(1-42) levels in the mild cognitive impairment stage of Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1002%2FRCM.2395

21 January 2018

Decreased CSF-beta-amyloid 42 in Alzheimer's disease and amyotrophic lateral sclerosis may reflect mismetabolism of beta-amyloid induced by disparate mechanisms.

1 reference

https://api.crossref.org/works/10.1002%2FRCM.2395

21 January 2018

Quantification of the A beta peptide in Alzheimer's plaques by laser dissection microscopy combined with mass spectrometry

1 reference

https://api.crossref.org/works/10.1002%2FRCM.2395

21 January 2018

Contact regions in the dimer of Alzheimer beta-amyloid domain [1-28] studied by mass spectrometry

1 reference

https://api.crossref.org/works/10.1002%2FRCM.2395

21 January 2018

Amyloid beta peptides in cerebrospinal fluid as profiled with surface enhanced laser desorption/ionization time-of-flight mass spectrometry: evidence of novel biomarkers in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1002%2FRCM.2395

21 January 2018

The amyloid-beta (Abeta) peptide pattern in cerebrospinal fluid in Alzheimer's disease: evidence of a novel carboxyterminally elongated Abeta peptide

1 reference

https://api.crossref.org/works/10.1002%2FRCM.2395

21 January 2018

Human cerebrospinal fluid peptidomics

1 reference

https://api.crossref.org/works/10.1002%2FRCM.2395

21 January 2018

Cerebrospinal fluid tau and beta-amyloid: how well do these biomarkers reflect autopsy-confirmed dementia diagnoses?

1 reference

https://api.crossref.org/works/10.1002%2FRCM.2395

21 January 2018

Possible involvement of copper(II) in Alzheimer disease

1 reference

https://api.crossref.org/works/10.1002%2FRCM.2395

21 January 2018

Oxidative stress and redox-active iron in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1002%2FRCM.2395

21 January 2018

Antioxidant neuroprotection in Alzheimer's disease as preventive and therapeutic approach

1 reference

https://api.crossref.org/works/10.1002%2FRCM.2395

21 January 2018

Cu(II) potentiation of alzheimer abeta neurotoxicity. Correlation with cell-free hydrogen peroxide production and metal reduction.

1 reference

https://api.crossref.org/works/10.1002%2FRCM.2395

21 January 2018

Cu(II)-catalyzed oxidation of beta-amyloid peptide targets His13 and His14 over His6: Detection of 2-Oxo-histidine by HPLC-MS/MS.

1 reference

https://api.crossref.org/works/10.1002%2FRCM.2395

21 January 2018

Metal binding and oxidation of amyloid-beta within isolated senile plaque cores: Raman microscopic evidence

1 reference

https://api.crossref.org/works/10.1002%2FRCM.2395

21 January 2018

Selective Cu2+/ascorbate-dependent oxidation of alzheimer's disease beta-amyloid peptides

1 reference

https://api.crossref.org/works/10.1002%2FRCM.2395

21 January 2018

Products of Cu(II)-catalyzed oxidation in the presence of hydrogen peroxide of the 1-10, 1-16 fragments of human and mouse beta-amyloid peptide

1 reference

https://api.crossref.org/works/10.1002%2FRCM.2395

21 January 2018

Methionine residue 35 is critical for the oxidative stress and neurotoxic properties of Alzheimer's amyloid beta-peptide 1-42.

1 reference

https://api.crossref.org/works/10.1002%2FRCM.2395

21 January 2018

The critical role of methionine 35 in Alzheimer's amyloid beta-peptide (1-42)-induced oxidative stress and neurotoxicity

1 reference

https://api.crossref.org/works/10.1002%2FRCM.2395

21 January 2018

Development of a methodology based on metal-catalyzed oxidation reactions and mass spectrometry to determine the metal binding sites in copper metalloproteins

1 reference

https://api.crossref.org/works/10.1002%2FRCM.2395

21 January 2018

Using mass spectrometry to study copper-protein binding under native and non-native conditions: beta-2-microglobulin

1 reference

https://api.crossref.org/works/10.1002%2FRCM.2395

21 January 2018

Methionine oxidation by reactive oxygen species: reaction mechanisms and relevance to Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1002%2FRCM.2395

21 January 2018

Alzheimer's disease amyloid-beta binds copper and zinc to generate an allosterically ordered membrane-penetrating structure containing superoxide dismutase-like subunits

1 reference

https://api.crossref.org/works/10.1002%2FRCM.2395

21 January 2018

Rapid characterization of amyloid-beta side-chain oxidation by tandem mass spectrometry and the scoring algorithm for spectral analysis

1 reference

https://api.crossref.org/works/10.1002%2FRCM.2395

21 January 2018

Cu(II) interaction with N-terminal fragments of human and mouse beta-amyloid peptide

1 reference

https://api.crossref.org/works/10.1002%2FRCM.2395

21 January 2018

Coordination abilities of the 1-16 and 1-28 fragments of beta-amyloid peptide towards copper(II) ions: a combined potentiometric and spectroscopic study

1 reference

https://api.crossref.org/works/10.1002%2FRCM.2395

21 January 2018

The antioxidant effect of tannic acid on the in vitro copper-mediated formation of free radicals

1 reference

https://api.crossref.org/works/10.1002%2FRCM.2395

21 January 2018

Influence of vitamin E and C supplementation on lipoprotein oxidation in patients with Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1002%2FRCM.2395

21 January 2018

Ascorbate compartmentalization in the CNS.

1 reference

https://api.crossref.org/works/10.1002%2FRCM.2395

21 January 2018

The Aβ Peptide of Alzheimer's Disease Directly Produces Hydrogen Peroxide through Metal Ion Reduction†

1 reference

https://api.crossref.org/works/10.1002%2FRCM.2395

21 January 2018

Identifiers

10.1002/RCM.2395

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16470704%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16470704%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46938051&oldid=2145814291"